Enterococcus faecalis (Andrewes and Horder) Schleifer and Kilpper-Balz
商品貨號(hào)
B161390
Verified By
Whole-genome Sequencing
Strain Designations
V583
Isolation
Human Blood from a patient, St. Louis Missouri, United States, 1987
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Lancefield's group D
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Preceptrol®
no
Genome Sequenced Strain
Enterococcus faecalis V583, complete genome
Type Strain
no
Antibiotic Resistance
Resistant to gentamicins gentamicin
Resistant to vancomycin
Sensitive to daptomycin
Sensitive to streptomycin
Comments
Genome sequenced strain
Presence of vanB gene confirmed by PCR.
Sensitive to streptomycin
Resistant to gentamicin
Resistant to vancomycin
Sensitive to daptomycin
Medium
ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor
MS Gilmore
Special Collection
NCRR Contract
Chain of Custody
ATCC <-- MS Gilmore <-- D Sahm
References
Sahm DF, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33: 1588-1591, 1989. PubMed: 2554802
Paulsen IT, et al. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 299(5615): 2071-2074, 2003. PubMed: 12663927
